The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

It Might Rain M&A at Merck Too

Following actual deals and expressions of interest by most of his peers, Merck’s CEO said he wouldn’t rule out a large transaction.

Bookmark and Share

About these ads

One response to “It Might Rain M&A at Merck Too

  1. adam hartung February 4, 2009 at 12:08 am

    Merck is using financial machinations to pretend it isn’t in big trouble due to insufficient new products. Merck has missed the market shift to biologics, and is trying to pretend all is fine. They should learn from Amazon, who just launched the Kindle to keep growing despite declining paper book sales. Read more at http://www.thephoenixprinciple.com/blog/2009/02/deception-vs-growth-merck-vs-amazon.html

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 126 other followers